Regulatory News has published 1 story about Precision Neuroscience on 26 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 26 September 2026.
This page is generated from Regulatory News’ editorial coverage of Precision Neuroscience. It is not an advertisement.
On the record
- Company
- Precision Neuroscience Corporation
- Headquarters
- New York, New York
- Founded
- 2021, by Michael Mager and Dr. Benjamin Rapoport, an original member of Neuralink’s founding team
- Regulator
- U.S. Food and Drug Administration (proceeds fund review beyond the device’s existing 510(k) clearance)
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
